Yahoo Finance

Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients

SAN DIEGO, CA / ACCESSWIRE / September 18, 2023 / Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on the development of AI-powered point-of-care ...
Yahoo Finance

Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

This clinical study will be conducted by the Infectious Disease Department at National Taiwan University Hospital, one of Taiwan's 25 designated medical centers for HIV management. The hospital ...
JSTOR Daily

Human Papillomavirus-Associated Oral Warts among Human Immunodeficiency Virus-Seropositive Patients in the Era of Highly Active Antiretroviral Therapy: An Emerging Infection

Oral warts are a manifestation of human papillomavirus infection that have been noted infrequently in persons with human immunodeficiency virus (HIV). A nested case-control study was conducted to ...
clinicaladvisor.com

Oral isotretinoin better than topical treatment for warts

Facial wart on a child. Oral isotretinoin showed the best response in cases of facial warts (HealthDay News) — Oral isotretinoin shows a better and earlier response than topical isotretinoin for the ...
Medical News Today

Does Medicare cover wart removal?

Medicare does not pay for benign wart removal for cosmetic reasons. However, it may fund the removal of malignant warts, warts that have spread to other body parts, or warts that are symptoms of ...